Haytaian Peter D 4
4 · Elevance Health, Inc. · Filed Mar 3, 2023
Insider Transaction Report
Form 4
Haytaian Peter D
EVP & Pres Carelon & CarelonRx
Transactions
- Tax Payment
Common Stock
2023-03-01$469.03/sh−607$284,701→ 11,354 total - Award
Common Stock
2023-03-01+2,292→ 13,646 total - Award
Common Stock
2023-03-01+9,716→ 23,362 total - Tax Payment
Common Stock
2023-03-02$468.78/sh−5,469$2,563,758→ 17,893 total - Award
Employee Stock Option (Right to Buy)
2023-03-01+8,812→ 8,812 totalExercise: $469.03Exp: 2033-03-01→ Common Stock (8,812 underlying)
Footnotes (4)
- [F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
- [F2]Represents restricted share units. Restrictions lapse as follows: 764 shares each on 3/1/2024, 3/1/2025 and 3/1/2026.
- [F3]Represents performance based restricted share units. Restrictions lapse on 3/2/2023.
- [F4]The option represents a right to purchase a total of 8,812 shares, and is exercisable in two installments of 2,937 shares each and one installment of 2,938 shares, beginning on 3/1/2024 which is the one-year anniversary of the option grant date.